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ABSTRACT
Objective: 2-pyridone is a well-known heterocyclic ring having significant biological and medical application. The molecular structures and various 
activities of 2-pyridone derivatives as well as their syntheses and natural occurrence are analyzed and reviewed, and their reactivity toward various 
nucleophiles is discussed.
Methods: 2-pyridone derivatives, first naturally obtained and described as early as before the 19th century, have been attracting increasing attention 
in view of their high reactivity as building blocks for the preparation of compounds of various classes due to their selective transformations with 
different reagents. Much information describing the natural occurrence, synthesis and the significant biological activity of 2-pyridone compounds are 
scattered throughout the literature. There are short chapters dealing with the synthesis and activity of 2-pyridone derivatives.
Results: After compiling the above material, the abundance of certain heterocyclic ring and nature of typical chemical transformations applied in 
current drug synthesis. It is likely this results from the abundance of these heterocycles in natural products such as alkaloids and various synthetic 
derivatives revealing different biological activity. This might suggest a classical approach to drug design where substrate analogs gain inspiration from 
existing natural ligands.
Conclusions: The data considered in this review clearly demonstrate the high synthetic potential of 2-pyridone derivatives. Many biologically active 
heterocyclic compounds have been obtained based on this heterocyclic ring. This suggests that 2-pyridone can be used in the design of novel highly 
effective pharmaceuticals with a broad spectrum of bioresponses.
Keywords: Naturally obtained 2-pyridone derivatives, Synthetic approach, Anticancer activity.
INTRODUCTION
2-pyridone is an organic compound with the formula C5H4NH(O). This 
colorless crystalline solid is used in peptide synthesis. It is well known 
to form hydrogen-bonded structures somewhat related to the base 
pairing mechanism found in RNA and DNA. It is also a classic case of a 
molecule that exists as tautomers [1].
2-pyridone catalyzes a variety of proton-dependent reactions. 
2-pyridone and some derivatives serve as ligands in coordination 
chemistry, usually as a 1,3 bridging ligand akin to carboxylate. 
A derivative has been isolated as a cofactor in certain hydrogenases [2]. 
The pyridine is found to have a large nunmber of biological activities 
those including antiviral, anticancer, antimicrobial, antidiabetic, and 
antitubercular [3]. In recent decades, a large number of pharmacological 
studies has been done on pyrimidine and their derivative. However, 
still more research is required to necessity the biological compounds. 
The pyrimidine derivatives show various biological activities including 
antitubercular, antioxidant, anti-inflammatory, anticonvulsant, 
antimicrobial, antibacterial, antiplasmodial, antifungal, anticancer, and 
analgesic activity [4].
NATURAL PRODUCTS CONTAINING 2-PYRIDONE
4-hydroxy-2-pyridone alkaloids exert diverse biological effects, ranging 
from antifungal, antibacterial, insecticidal and cytotoxic activity to the 
induction of neurite outgrowth in different cell assays [5]. For this 
reason, this class of compounds has attracted much attention in the 
scientific community, resulting in the elucidation of the biosynthesis 
of some members which are formed by fungal polyketide synthases 
through tetramic acids by fungal polyketide synthases as well as 
different total synthesis approaches [6].
2-pyridones are important compounds that are found in many active 
natural products and pharmaceuticals (Fig. 1) [7]. The history of the 
pyridone alkaloids dates back to the 19th century, when Tuson isolated 
from castor beans a poisonous crystalline substance which he called 
ricinine [8]. The structural elucidation was accomplished in 1904 proposed 
the 2-pyridone core structure [9]. Many decades later, after preliminary 
data for two yellow pigments isolated from the insect pathogenic fungi 
Beauveria bassiana and Beauveria tenella in 1968 had been published, the 
structural features of the two fungal biochromestenellin and bassianin 
were unravelled in 1974 [10]. In the meantime, more pyridone alkaloids 
were isolated, e.g., flavipucine (1968), funiculosin (1969), ilicicolin H 
(1971), and the antibiotic kirromycin as a representative of the elfamycins. 
These findings enriched the field of pyridone alkaloids in natural product 
chemistry, which was opened in 1864 and still continues today, as 
fascinating structures are still being discovered [11]. These pyridone-
based molecules have shown a broad range of biological properties such 
as antifungal, anti-HIV, antitumoral, anti-hepatitis B, MEK-1 inhibitors, 
receptor tyrosine kinase c-Kit inhibitors, anaplastic lymphoma kinase 
inhibitors, antimycobacterium tuberculosis agents, human rhinovirus 3C 
proteases, and anti Pim-1 kinase activities [12].
The 4-hydroxy-2-pyridone heteroaromatic core is increasingly attracting 
the attention of scientific community due to its abundance of their in natural 
2-pyridones alkaloid family and its implication in important biological 
systems [13]. Its biological action is mainly depended on the molecular 
decoration presented at 3 and 5-positions of its core (Fig. 2). Specific 3-
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acyl-substituted derivatives were recognized as important neuritogenic 
compounds targeting the stress pathway kinase MAP4K4 [14]. On the 
other hand, selected 3-alkyl derivatives were documented as potent 
antibacterials and antimalarials, potentially through their ability to 
Fig. 1: Few naturally occurring 2-pyridones
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chelate iron [15]. Furthermore, bicyclic analogs of 2-pyridones, utilizing 
the 4-hydroxy-substituent in cycloetheric rings were also found to 
possess potent antibacterial activities [16]. Interestingly, aromatic bicyclic 
pyridones and especially furo[3,2-c]-pyridones-2 and their 2- and 4-thio-
derivatives were utilized as unnatural base pairs for the in vivo expansion 
of an organism’s genetic alphabet and the prophylaxis or the treatment of 
obesity [17]. In Fig. 3, some important 4-hydroxy-2-pyridone have been 
listed which have shown potent bioactivity against cancer [18].
Although pyridone-2 derivatives are increasingly filling the biological active 
space, still their true biological profile is hampered by the unavailability 
of simple protocols for their synthesis. The past 5 years, tremendous 
efforts have been witnessed in utilizing direct functionalization 
practices to enrich the synthetic libraries of 2-pyridones and simplify 
synthetic protocols [19]. Following these efforts, pyridone-2 core and 
heteroaromatic analogs have been able to be functionalized selectively in 
5- and 3-positions by utilizing mainly electrophilic palladation or radical 
initiated SOMO/HOMO interaction and in the 6-position by nucleophilic 
metal addition [20]. On the other hand, the literature is particularly poor 
when describing the direct functionalization of 4-hydroxy-2-pyridones. To 
the best of our knowledge, only couple of references exist describing their 
direct 3-alkylation, 3-arylation and very recently their 3-alkenylation with 
a limited number of activated styrenes byutilizing modified palladium-
catalyzed Tzuji-Trost, Suzuki and Heck-type reactions, respectively [21]. 
Surprisingly, none of the reports have described the direct access of 
asymmetric alkylation in 4-hydroxy-2-pyridone core structure and their 
application in drug development for cancer treatment [22].
a. Synthesis of citridone core structure by multi-step Tzuji-Trost 
reaction (L. Zografos et al.):
b. Synthesis of citridone core structure by metal catalyzed direct C-H 
functionalization (L. Zografos et al.):
c. Total synthesis of citridone (L. Zografos et al.):
d. Semi synthesis of YCM1008A core structure (L. Zografos et al.):
DEFINITION OF THE PROBLEM
4-hydroxy-2-pyridone alkaloids constitute a family of natural products 
that is extremely wealthy in diverse biological activity and pharmaceutical 
applications mainly in cancer therapy [23]. Despite the increasing 
knowledge provided by the large number of isolated compounds of 
their family, numerous unanswered questions remain concerning their 
biosynthesis, unknown congeners, and most importantly their biological 
targets. Seeking to uncover missing biosynthetic links between 
apparently unrelated natural compounds, our interest focused on 
(1) development of novel synthetic strategy to introduce chiral center at 
3-position of 4-hydroxy-2-pyridones (Fig. 4a) (2) development of novel 
synthetic strategy to construct furo[3,2-c]pyridin-4(5H)-one derivatives 
(Fig. 4b) and (3) study their potential activity to treat breast cancer [24].
STRUCTURES, NATURAL SOURCES, AND KNOWN BIOACTIVITIES
Due to the diversity of the pyridone natural products, they will 
be discussed with respect to the linkage in the 3-position, i.e., 
3-acyl- 3-ether- and 3-alkyl-modified 2-pyridones. The following 
Fig. 3: Some important 2-pyridone derivatives have shown 
excellent activity against cancer cells
Fig. 2: (a) Potential bioactive position (3- and 5-) of 4-hydroxy-
2-pyridone core structure. (b) Important naturally occurring 
2-pyridone alkaloid family having 3- and 5-substituted 4-hydroxy-
2-pyridone core structures
ba
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schemes will summarize the known structures. Although the elfamycin-
type pyridones also contain a 3-acyl modification, these compounds 
have been grouped separately for reasons of clarity [25].
The first group contains all 4-hydroxy-3-acyl-modified 2-pyr-idones 
and ricinine (1) (Scheme 1). Ricinine (1) is an insecticidal and 
hepatotoxic alkaloid produced by Ricinus communis which is present in 
high concentrations in the whole plant (ca. 1 mg/g fresh weight) [26]. 
The cytotoxic aspyridones A and B were discovered in the filamentous 
fungus Aspergillus nidulans as the product of a silent PKS-NRPS cryptic 
gene cluster. This gene cluster was activated by ectopic expression 
under control of an inducible promoter. With this technique, the best 
producer strain generated 2 and 3 from 0.5 to 1 mg/L of culture broth, 
enough to determine the relative configuration [27]. This discovery 
bears the implication that different pyridone alkaloids may still be found 
hidden in silenced gene clusters in many other species. Aspyridone B 
(3) is the only known pyridone alkaloid containing a catechol moiety, 
whereas the p-hydroxyphenyl moiety is found in many other pyridone 
alkaloids. Pyridovericin is one of the many examples featuring this 
substitution pattern. Originally isolated from the entomopathogenic 
fungus B. bassiana in 1998, it was found to inhibit protein tyrosine 
kinase at high concentrations (100 mg/mL) in crude cell homogenates 
from NIH3T3/v-src1.12. Its absolute configuration was determined by 
a very interesting quasi-racemic synthesis in 2002, 13 [2]. A group of 
similar pyridone alkaloids are the yellow biochromestenellin and its 
congeners pre-tenellin, bassianin and farinosone A and B. Tenellin was 
first isolated from the entomopathogenic fungus B. tenella in 1968 and 
later also found in B. bassiana [28]. Along with bassianin, it was found 
to be an inhibitor of ATPase in isolated membranes. Studies to unravel 
the biosynthesis of tenellin have been performed, which are beyond the 
scope of this article. In general, however oxidative ring expansion of 
tetramic acids to 2-pyridones is thought to be the process involved. Two 
racemic syntheses of tenellin were developed in 1982 and 1989, but the 
absolute configuration still remains unknown [29]. Pre-tenellin B was 
isolated after knockout of one of the two open reading frames encoding 
for a cyp450 oxidase using RNA silencing techniques. Therefore, pre-
tenellin B was found to be the direct precursor of tenellin [30]. More 
recently, the tetraene 2-pyridones farinosone A and B along with the 
biosynthetically related farinosone C have been isolated from the 
entomopathogenic fungus Paecilomyces farinosus by bioassay-guided 
fractionation [31]. Farinosone A-induced neurite outgrowth in the PC-12 
assay, whereas farinosone B was inactive. The absolute configuration of 
these natural products remains unknown. Other closely related natural 
products are the militarinones [6,7], isolated from the mycelium of the 
entomogenous fungus Paecilomyces militaris (or P. farinosus) in the years 
2002-2006. These natural products induced neurite outgrowth in the 
PC-12 assay at low concentrations by persistently activating the PI3-K/
PKB and the MEK/ERK pathways. Militarinone A was also capable of 
inducing apoptosis in the murine neuroblastoma cell line N2a by nuclear 
translocation of the apoptosis-inducing factor [32]. Deoxymilitarinone 
A was cytotoxic in human neuronal IMR-32 cells at concentrations of 
100 mM. It is interesting to note that its hydroxamic acid was isolated 
from two different strains differed in their signs of optical rotation, 
although homochirality of these compounds may not generally be 
assumed. The relative configuration, however, has been tentatively 
assigned as syn. Pyridomacrolidin is the only known pyridone alkaloid 
containing a 10-membered cyclic lactone. It was isolated in 1998 from 
B. bassiana along with pyridovericin and found to be a weak inhibitor 
of protein tyrosine kinase. The absolute configuration is unknown, 
and there is only one recent study toward a biomimetic synthesis [33]. 
The antifungal antibiotic ilicicolin H was isolated in 1971 from the 
mycelium of the imperfect fungus Cylindrocladium ilicicola. Its absolute 
configuration and biosynthesis have been investigated [34]. In addition, 
in 1985 a racemic total synthesis using an intra-molecular Diels–Alder 
strategy was presented [35]. Harzianopyridone was isolated in 1989 
from the fungus Trichoderma harzianum as a racemic mixture and 
reported to be an antifungal agent. Later on, a levorotatory sample 
was also found to be inhibitory toward etiolated wheat coleoptiles 
(herbicidal) and an inhibitor of the mitochondrial complex II [36].
In 1988, the three antifungal antibiotics atpenin B, A4 and A5 
were isolated from Penicillium sp. followed by the total structural 
elucidation in 1990 of atpenin A 4 by X-ray crystallography [36,37]. 
Like harzianopyridone, the atpenins were found to be mitochondrial 
complex II inhibitors. Atpenin B was obtained in racemic form from 
a total synthesis in 1994, whereas atpenin A5 was stereoselectively 
synthesized in 2009 [38].
The second group comprises the 4-oxy-3-alkoxy-2-pyridones shown in 
Scheme 1. TMC-69 is an antitumor antibiotic from Chrysosporium sp. 
that induced prolongation of the survival time of mice transplanted 
with B16 melanoma and P388 leukemia. The absolute configuration 
of the THP-moiety could be determined by degradation studies, while 
the stereogenic center of the side chain remains unassigned and 
transformed it into its stable hexahydrogenated form TMC-69-6 [39]. 
Hand reported that this molecule was a selective inhibitor of the 
Scheme 1: Known synthetic strategy to construct highly biologically potent 3,5-substituted 4-hydroxy-2-pyridones
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dual specificity phosphatases Cdc25 A and B. It was found a different 
phosphatase inhibition profile with low inhibition of Cdc25A but high 
inhibition of other phosphatases, e.g., PTP1B and VHR [39]. Fusapyridon 
A and its dimethyl ketalfusapyridon B were isolated in 2007 from 
Fusarium sp. and fusapyridon A exhibited antimicrobial activity 
against Pseudomonas aeruginosa and Staphylococcus aureus [40]. Their 
structures resemble 4, 60-anhydro-oxysporidinone from an endophytic 
strain of Fusariumoxysporum, with fusapyridone A. The absolute 
stereostructure and parts of the relative configuration remain to be 
solved. 4, 60-anhydro-oxysporidinone has so far not been found to exert 
any biological activity in laboratory systems [40,41].
Funiculosin with broad antifungal properties was discovered as early 
as 1969. Its absolute stereostructure was solved in 1978 by X-ray 
crystal structure analysis and hydrogenation experiments. It was the 
first natural product containing a unique all-syncyclo pentanetetrol 
moiety [42].
Tricyclic biarylleporins A and B were isolated from Aspergillus leporis 
in 1991 and 2003, respectively. Leporin A (33) shows activity against 
the corn earworm Helicoverpa zea and moderate antibacterial activity 
against Bacillus subtilis. The relative stereostructure of leporin A was 
solved and verified in a racemic total synthesis in 1996 [42,43]. Leporin 
B is an inducer of the hexokinase II gene (HKII). It was identified with 
a rat myoblast cell construct expressing the reporter gene luciferase 
under control of the HKII promoter. Thus, enhancement of HKII 
transcription enhanced the luciferase signal [43,44]. The relative 
configuration was solved by X-ray diffraction. It was active in the Rev 
binding assay, rendering it a potential antiviral substance, and was also 
active against Candida albicans and Penicillium chrysogenum (MICs 16 
and 8 mg/mL, respectively). Its antitumor potency was found in vitro but 
not in vivo against Madison lung carcinoma cell line M109 (1 mg/mL). 
Epipyridone is the p-hydroxyphenyl modified derivative of fusaricide. 
Its natural source is the endofungal filamentous fungus Epicoccum sp. 
The authors suggest an interesting biosynthetic proposal for the side 
chain through an intramolecular hetero-Diels–Alder reaction, which 
would also be valid for the construction of the structures, e.g., fusaricide 
and PF1140. No bioactivity has yet been assigned for epipyridone, and 
only the relative configuration is known [45].
Hence, many researcher have focused on leukemia treatment. Primary 
treatments available for leukemia are radiotherapy, bone marrow 
transplant, biotherapy, surgery, and chemotherapy. BCR-ABL tyrosine 
kinase inhibitor, e.g., imatinib mesylate has revolutionized and set the 
landmark in this field [46]. PIM-1 (Proto-oncogenic encodes for serine/
threonine kinase) kinase have been shown to be overexpressed in a 
variety of cancer cell lines. 2-oxo-3-cyanopyridine derivative, 4,6-diaryl-
2-oxo-1,2- dihydropyridine-3-carbonitriles has shown inhibition of the 
oncogenic serine/threonine kinase PIM-1, which plays a role in cancer 
cell survival, differentiation and proliferation [47].
Synthetic approach
The 2-pyridone derivatives were synthesized by various scientists, by 
approaching deferent versatile route and exhibiting various activities.
Karam et al. 2014 reported as Src kinase, a prototype member of the 
Src family of kinases, is over-expressed in various human tumors and 
has become a target for anticancer drug design. In this perspective, 
a series of eighteen 2-pyridone derivatives were synthesized from 
corresponding. In the case of dihydroxyacetophenone, first, mono-O-
acetylation was carried out using acetic anhydride and pyridine while 
o-hydroxyacetophenone was used as such. 4-Oxo-4H-1-chromen-
3-yl-carbaldehydes were then synthesized using Vilsmeir-Haack 
formylation reaction and evaluated for their c-Src kinase inhibitory 
activity. Among them, eight compounds exhibited c-Src kinase 
inhibitory activity with IC50 value of less than 25 μM. Compound 
1-[2-(dimethylamino) ethyl]-5(2-hydroxy-4-methoxy benzoyl) 
pyridin-2(1H)-one exhibited the highest c-Src kinase inhibition with 
an IC50 value of 12.5 μM [48].
(b) POCl3, DMF, 50°C, 13 h; (c) CH2(COOH)2, pyridine, 1.5 h; (d) EtOH, 
conc. H2SO4 (3 or 4 drops), 12 h; (e) CH3I, K2CO3, anhyd.acetone, 
reflux, 12 h.
Mijin et al. 2014 synthesized 2-pyridones as well as 2-pyridone-based 
compounds, such as 2-quinolones, using microwave assisted organic 
chemistry is reviewed. N-substituted 4,6-dimethyl-3-cyano-2-pyridones 
were obtained from acetylacetone and the corresponding N-substituted 
cyanoacetamide using conventional and microwave synthesis in the 
presence of piperidine as a catalyst gave a good yield [49].
Where R1=H, CH3; R2=H,CH3; R3=C6H5
Seifi et al. 2013 Magnesium oxide and bismuth(III) nitrate pentahydrate 
as highly effective catalysts which have catalyzed the three-component 
reaction of cyanoacetic acid hydrazide, aldehydes, and malononitrile to 
prepare of the corresponding N-amino-2-pyridones [50].
Mehrparvar et al. 2013 prepared a novel analog of 2-pyridone-
3-carboxylic acids by the three-component reaction of 3-formyl 
chromone, Meldrum’s acid, and primary amines in the presence of a 
catalytic amount of diammonium hydrogen phosphate in water. Good-
to-high yields, easy work-up, and an environment- tally friendly profile 
are the advantages of this method for the synthesis of 2-pyridone-3-
carboxylic acid derivatives [51].
R=H, Cl, Br
Al-Abdullah 2011 prepared the title compounds by reaction 
of 6-acetyltetralin with different aromatic aldehydes, namely, 
2,6dichlorobenz-aldehyde, 2,6-diflourobenzaldehyde, and 3-ethoxy-
4-hydroxybenzaldehyde, to yield the corresponding α,β-unsaturated 
ketones 3a-c. Compound 3b was reacted with hydrazine hydrate to yield 
the corresponding 2-pyrazoline 4, while compounds 3a,b reacted with 
thiourea to afford the 2-thioxopyrimidine derivatives 5a,b, respectively. 
The reaction of 1, and the aromatic aldehydes 2a-c with ethyl 
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cyanoacetate, 2-cyano-thioacetamide or malononitrile in the presence 
of ammonium acetate yielded the corresponding 2-oxopyridines 
6a,b, 2-thioxopyridines or 2-iminopyridines, respectively. The newly 
prepared compounds were evaluated for anticancer activity against 
two human tumor cell lines. Compound 3a showed the highest potency 
with IC50=3.5 and 4.5 μg/mL against a cervix carcinoma cell line (Hela) 
and breast carcinoma cell line (MCF7), respectively [52].
Lv et al. 2010 synthesized a series of novel 2-pyridone derivatives and 
evaluated for their antihepatitis B virus (HBV) activity and cytotoxicity 
in vitro. Moderate to good activity against HBV DNA replication was 
observed in these 2-pyridone analogs. The most active compounds were 
5d and 6l, with good inhibitory activity against HBV DNA replication 
(IC50=0.206 and 0.12 μM, respectively) and remarkable high selectivity 
(selectivity indexes of >532 and 467, respectively). A pharmacophore 
model of the synthesized compounds was proposed by the GASP program. 
The pharmacophore model consists of three hydrophobic points, four 
HBA points, and one HBD point. The 2-pyridone derivatives represent a 
novel class of HBV inhibitors, which are worth further optimization [53].
R=H, 4-OCH3, 2-OCH3, 4-OCH2CH3
Tkachova et al. 2010 reported a sodium ethoxide catalyzed reaction 
of N-substituted cyanoacetanilides with diethyl 2-(ethoxymethylene)
malonate unexpectedly leads to the corresponding 2-amino-5-cyano-
6-oxo-N,1-diaryl-1,6-dihydropyridine-3-carboxamides, while the 
expected 5-cyano-2-hydroxy-6-oxo-1-aryl-1,6-dihydropyridine-3-
carboxylates were observed only as minor products [54].
Jacinto et al. 2009 reported a commercial dehydroacetic acid was 
converted into 4-hydroxy-6-methylpyridin-2(1H)-one (3), which was 
then condensed with several aliphatic aldehydes to produce seven 
new title compounds in variable yields (35-92%). Reaction with α, 
β-unsaturated aldehydes resulted in the formation of condensed pyran 
derivatives. A mechanism is proposed to explain the formation of such 
compounds. The effects of all methylpyridin-2(1H)-one derivatives on 
the development of the dicotyledonous species Ipomoea grandifolia and 
Cucumis sativus, and the monocotyledonous species Sorghum bicolor were 
evaluated. At the dose of 6.7×10−8 mola.i./g substrate, the compounds 
showed some phytotoxic selectivity, being more active against the 
dicotyledonous species. These compounds can be used as lead structures 
for the development of more active phytotoxic products [55].
i=H2SO4, 130oC,10 min.; (ii) NH4OH, 100°C, 6Hrs, (iii) ethanol/
methanol, piperidine, pyridine (iv) RCHO; R=CHO
Tugusheva et al. 2006 reported new approaches to the synthesis 
of the previously unknown pyrimidine, 4-amino-2-pyridone, and 
4-aminopyridine derivatives were developed based on the reactions 
of enamino amides with dimethylformamide dimethyl acetal. New 
structural modifications of 4-amino-2-pyridone derivatives were 
performed. Numerous compounds of this type, which are of interest for 
biological studies, were prepared [56].
Yu et al. 2006 reported a catalytic oxidative coupling between 
acrylamides and alkynes was achieved using 0.5 mol% loading of 
[RhCp*Cl2]2 with Cu(OAc)2 as an oxidant. 2-pyridones, iminoesters, 
and substituted indoles could be obtained as a result of the electronic 
and steric effects of the substituents in the acrylamides [57].
Ando et al. 2006 synthesized a novel one-pot synthesis of 
N-difluoromethyl-2-pyridones is described. N-(pyridin-2-yl)
acetamide derivatives were excellent precursors for the preparation 
of N-difluoromethyl-2-pyridone derivatives. Difluoromethylation 
of 2-acetaminopyridine derivatives was achieved with sodium 
chlorodifluoroacetate as a difluorocarbene source in the presence 
of a catalytic amount of 18-crown-6. Subsequent in situ hydrolysis 
of resultant 1,2-dihydro-2-acetimino-1-difluoromethylpyridines 
proceeded under mild acidic conditions to afford the corresponding 
N-difluoromethyl-2-pyridones in moderate to good yields [58].
Kajal and Devakumar 2005 reported augmentation of wheat production 
calls for introduction of wheat hybrids in cultivation. In the absence of 
viable alternative technology of hybrid wheat development, chemical 
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induction of male sterility mediated technology based on chemical 
hybridizing agents (CHAs) holds a great potential. The QSAR method 
was applied to two families of CHAs in the N-acylanilines and pyridone 
class of chemistry.
The models for each CHA family gave good correlation between the 
variations in log percent of male sterility and the steric-electrostatic 
properties of the sets. QSAR analysis has revealed a direct relationship 
of the Swain-Lupton constant Fp and molecular mass but an inverse 
relationship of molar refractivity (MR), ES, and Swain-Lupton resonance 
constant R in influencing the bioactivity in the N-acylanilines. QSAR 
analysis of four parent families consisting of two training sets each of 
pyrid-2-ones and prid- 4-ones revealed the positive contributions of 
field effect exemplified by the Swain-Lupton field constant (F) and the 
negative contributions of the MR of aromatic substituents in all but 
one training set. The QSAR models also indicated that increased steric 
bulk at the 4-position on the phenyl ring is associated with enhanced 
activity [59].
Desai et al. 2006 reported a series of benzimidazole bearing 2-pyridones 
5a–k were synthesized and assessed in vitro for their activity as 
antimicrobial agents using the conventional broth dilution method. The 
results of the antimicrobial study revealed that compounds exhibited 
substantial antibacterial activity and emerged as a more potent 
antifungal agent compared to the standard drugs chloramphenicol 
and ketoconazole, respectively. It was observed that the presence of 
inductively electron withdrawing groups remarkably enhances the 
antibacterial activity of the newly synthesized compounds. Cytotoxicity 
studies suggested that none of the tested compounds exhibited any 
significant cytotoxic effects [60].
Fischer et al. 2004 synthesized series of 3-cyano-pyridones carrying 
a variety of alkyl substituents at C-5 and C-6 have been synthesized 
and their solid-state structures have been studied. Hydrogen bonding 
interactions between individual pyridone molecules lead either to 
the formation of symmetric dimers of the R22 (8) type or to helical 
chains of the C (4) type, which was based on the known and calculated 
structures for the 2-pyridone parent system [61].
CONCLUSIONS
Pyridone alkaloids constitute a remarkable class of secondary 
metabolites. Due to their diversity, many different biological effects of 
these compounds have been identified, which may, however, not always 
be related to their original biological function. Their versatile and 
diverse structures resulting from different modifications in all positions 
of the pyridone core should render these compounds a fascinating 
playground for synthetic chemists for many decades. Despite the 
innovative synthetic approaches that have been developed to obtain 
these natural products, much work remains to be done, as many of the 
known structures have not been determined in full detail. Likewise, the 
synthesis of derivatives to generate structure-activity relationships has 
not found too much attention. The original biological functions of these 
secondary metabolites remain largely unknown despite speculations 
about the metal-sequestering properties of hydroxamic acids. Other 
biological aspects, e.g., the biosynthesis of tenellin, have been clarified 
in great detail. Other closely related structures such as (for example) 
the lycopodium alkaloids have been reviewed, 116 and there are many 
more related structures incorporating the 2-pyridone core. It is also 
noteworthy that the 2-pyridone structure can be found in approved 
drugs such as milrinone, 117, 118 making these compounds and the 
development of various versatile synthetic approaches a fusion of 
natural product as well as synthetic product in medicinal chemistry.
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